Physician profile
Fred Galluccio
NPI 1104934397
$914.94
in general payments reported to CMS, 2019-2025
17 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $26.87 · 2021: $25.70 · 2022: $132 · 2023: $130 · 2024: $285 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $278.30 | 2023-2025 | Repatha, Otezla, Otezla |
| Amarin Pharma, INC. | $129.64 | 2019 | |
| Inari Medical, INC. | $66.64 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $62.01 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Novartis Pharmaceuticals Corporation | $57.10 | 2022 | |
| Sanofi Pasteur INC. | $56.57 | 2019-2023 | |
| Exact Sciences Corporation | $32.14 | 2024 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $29.01 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $27.92 | 2024 | Oxlumo |
| Glaxosmithkline, LLC. | $27.10 | 2022 | |
| Boston Scientific Corporation | $26.41 | 2025 | General - Pain Management |
| Pfizer INC. | $25.70 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.14 | 2025 | Airsupra |
| Biohaven Pharmaceutical Holding Company LTD. | $24.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.10 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.33 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Galluccio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.